Horizontal Ridge Augmentation of the Mandible Autogenous Block Grafts
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
20 subjects presenting with horizontal mandibular ridge width less than 5 mm were selected and randomly divided two groups (10 in each group). the first group received interpositional block grafts (harvested from the chin and ramus) covered with Platelet-rich fibrin membrane. the second group received onlay block grafts (harvested from the chin and ramus) and covered with Platelet-rich fibrin membrane. the grafts are left for 4 months. the alveolar ridge width dimensions is then measured using radiographic analysis using cone-beam computed tomography scans
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 6, 2017
CompletedFirst Posted
Study publicly available on registry
June 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedJuly 11, 2017
July 1, 2017
1.1 years
June 6, 2017
July 6, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
alveolar ridge width gained
radiographic analysis following ridge augmentation using Cone beam computed tomography
4 months
Secondary Outcomes (1)
patient morbidity following the surgical procedure
14 days
Study Arms (2)
Interpositional block graft
EXPERIMENTALridge split interpositional block graft
Onlay block graft
ACTIVE COMPARATORdecortication onlay block graft
Interventions
Eligibility Criteria
You may qualify if:
- Patients of both sexes with a minimum vertical bone height above the inferior alveolar canal of 10mm in the edentulous region.
- Patients should have ridge thickness less than 5mm measured 2mm from the alveolar crest Patients should be free from any systemic disease that may affect normal healing of bone, and predictable outcome.
You may not qualify if:
- Patients with any systemic disease that may affect normal bone healing. Patients with drug allergies, drug or alcohol abuse, periodontal diseases or poor oral hygiene
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
June 6, 2017
First Posted
June 12, 2017
Study Start
July 1, 2016
Primary Completion
August 1, 2017
Study Completion
September 1, 2017
Last Updated
July 11, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will share